Delivery Order SPE2DB20D3103-SPE2DB23FP0Y5
Award Date 7/24/23
Potential Completion Date 7/25/23
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of a pharmaceutical product called MULTIHANCE 529 MG/ML VIAL 10ML. The contract has a firm fixed price of $3,048.50 and a period of performance through November 25, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $5,730.00. It was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,049.00 firm fixed-price delivery order is for the pharmaceutical product MULTIHANCE 529 MG/ML VIAL 10ML. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product Multihance 529 mg/ml vial 20ml. The contract has a ceiling value of $9,132.20 and a completion date of June 2, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The award has a ceiling value of $1,513.68 and runs through September 26, 2024. There is no set-aside designation indicated for this contract. AmerisourceBergen, through its Corporate Office Division, is the prime contractor for this order. This award is likely part of a larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,111.77 for MULTIHANCE 529MG/ML 5S, a contrast agent pharmaceutical product, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed price, non-competitive set-aside delivery order is due for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $3,871.30. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 24, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials, to support military treatment facilities and...